
Ocular Insights: Understanding Genetic Testing for Oculocutaneous Albinism Type 7
Explore genetic testing's role in diagnosing and managing Oculocutaneous Albinism Type 7, offering insights into personalized care and future treatment advancements.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Explore genetic testing's role in diagnosing and managing Oculocutaneous Albinism Type 7, offering insights into personalized care and future treatment advancements.

Explore Osteogenesis Imperfecta Type 14, its SP7/OSX mutation, and the role of genetic testing in diagnosis, personalized treatment, and family planning.

Explore how genetic testing enhances diagnosis and management of Osteogenesis Imperfecta Type 15, offering insights for personalized treatment and family planning.

Unlock the secrets of osteosclerotic metaphyseal dysplasia. Genetic testing offers definitive diagnosis, personalized treatment, and insights for family planning.

Explore how genetic testing facilitates accurate diagnosis, personalized treatment, and informed family planning in Palmoplantar Keratoderma, Nagashima type.

Unlock the role of genetic testing in diagnosing Paroxysmal Nocturnal Hemoglobinuria, offering early diagnosis, personalized treatment, and insights into disease progression.

Explore how genetic testing aids in early diagnosis, personalized care, and research advancements for Perrault Syndrome 4, a rare mitochondrial disorder.

Unlock the role of genetic testing in diagnosing Phosphohydroxylysinuria, a rare metabolic disorder. Explore the impact on family planning and personalized treatment.